Terence J O'Brien
Terence J O'Brien is an expert in Neurology at Royal Melbourne Hospital (Australia). As of October 2026, ScienceLeadR ranks Terence J O'Brien in the top 1% of experts worldwide for Epilepsy, Seizures and Brain Injuries. Terence J O'Brien has authored 975 publications, the most recent in 2026, and is an investigator in 14 clinical trials, 1 of them ongoing. SLR score: 6,572 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Public Health - Hematology - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 2002 - 2026
Number : 975
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Mortality in two independent First Seizure Clinic cohorts up to 20 years post epilepsy diagnosis. PMID 42731248 — epilepsy, mortality, mental disorders, neoplasms, preexisting condition coverage, seizures, diagnosis | Epilepsy Behav | 2026 | 0 |
| Internet Intervention for Functional Seizures: A Randomized Clinical Trial. PMID 42931745 — depression, quality of life, internet, internet-based intervention, seizures, therapeutics, nervous system diseases, random allocation | JAMA Neurol | 2026 | 0 |
| Early neurocognitive outcomes following SEEG with radiofrequency thermocoagulation. PMID 42897841 — neuropsychology, epilepsy, language, electrocoagulation, neuropsychological tests, telemedicine, recycling, work, counseling, cognition | Epilepsia Open | 2026 | 0 |
| Limited sex-specific structural alterations across common epilepsies: A worldwide ENIGMA study. PMID 42873626 — epilepsy, neuroimaging, epilepsy, temporal lobe, sex characteristics, sex, sex differences | Epilepsia | 2026 | 0 |
| Patient-reported symptom burden after chimeric antigen receptor T-cell therapy. PMID 42747063 — cells, receptors, antigen, receptors, chimeric antigen, therapeutics, t-lymphocytes, cognition, receptors, antigen, t-cell | Br J Haematol | 2026 | 0 |
Clinical Studies 14
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 17
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| PRECISION TBI An Observational Study of Patients With Moderate to Severe Traumatic Brain Injury NCT05855252 — brain injuries, brain, multiple chronic conditions, cohort studies, brain injuries, traumatic, therapeutics, wounds and injuries | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map